Ken Bradstock

Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial

Xavier Thomas, Jean-Michel Boiron, Françoise Huguet et al. · Journal of Clinical Oncology · 2004 · 541 citations · Full text

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

JF Bishop, JP Matthews, G. A. R. Young et al. · Blood · 1996 · 459 citations · Full text

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 336 citations · Full text

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

Harry Iland, Marnie Collins, Ken Bradstock et al. · The Lancet Haematology · 2015 · 165 citations

Hematological Malignancy, Oncology, Malignant Blood Disorder +8

Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation

Kenneth Micklethwaite, Anna M. Hansen, Aaron E. Foster et al. · Biology of Blood and Marrow Transplantation · 2007 · 130 citations · Full text

Ex Vivo Expansion, Cell Therapy, Immunology +17